If Fluticare gets approved, then this one will no longer be a penny stock. I have seen projection of $1 billion dollar a year for this product and if that's true, we may be looking at a $10 stock long term.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.